Gene Network Sciences, based in Cambridge, MA, is a leading AI-enabled biotech company focused on uncovering hidden biological mechanisms of disease and developing breakthrough drugs. Through the use of causal AI, human multi-omics data, and Gemini Digital Twins, the company aims to accelerate the discovery of life-saving therapeutics to positively impact patient lives.
With a pipeline prioritizing neurodegenerative diseases, Gene Network Sciences boasts a world-class team of AI pioneers, R&D veterans, and biotech experts dedicated to advancing drug discovery. The company collaborates with industry leaders to drive innovation in AI-enabled drug discovery and shape the future of biotech.
Generated from the website